MAHLY
Price
$18.03
Change
+$0.65 (+3.74%)
Updated
Dec 18 closing price
Capitalization
3.66B
Intraday BUY SELL Signals
NSVGF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
3.29M
Intraday BUY SELL Signals
Interact to see
Advertisement

MAHLY vs NSVGF

Header iconMAHLY vs NSVGF Comparison
Open Charts MAHLY vs NSVGFBanner chart's image
Medipal Holdings
Price$18.03
Change+$0.65 (+3.74%)
Volume$165
Capitalization3.66B
Nass Vy Gateway
PriceLoading...
Change-$0.00 (-0.00%)
Volume$34.5K
Capitalization3.29M
MAHLY vs NSVGF Comparison Chart in %
MAHLY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MAHLY vs. NSVGF commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Hold and NSVGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (MAHLY: $18.03 vs. NSVGF: $0.01)
Brand notoriety: MAHLY and NSVGF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 28% vs. NSVGF: 100%
Market capitalization -- MAHLY: $3.66B vs. NSVGF: $3.29M
MAHLY [@Medical Distributors] is valued at $3.66B. NSVGF’s [@Medical Distributors] market capitalization is $3.29M. The market cap for tickers in the [@Medical Distributors] industry ranges from $102.23B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 1 FA rating(s) are green whileNSVGF’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 1 green, 4 red.
  • NSVGF’s FA Score: 0 green, 5 red.
According to our system of comparison, MAHLY is a better buy in the long-term than NSVGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 4 TA indicator(s) are bullish.

  • MAHLY’s TA Score: 4 bullish, 2 bearish.

Price Growth

MAHLY (@Medical Distributors) experienced а 0.00% price change this week, while NSVGF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +4.14%. For the same industry, the average monthly price growth was +0.64%, and the average quarterly price growth was +3.36%.

Industries' Descriptions

@Medical Distributors (+4.14% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.66B) has a higher market cap than NSVGF($3.29M). MAHLY YTD gains are higher at: 12.162 vs. NSVGF (0.000).
MAHLYNSVGFMAHLY / NSVGF
Capitalization3.66B3.29M111,378%
EBITDA95.3BN/A-
Gain YTD12.1620.000-
P/E Ratio14.36N/A-
Revenue3.74TN/A-
Total Cash277BN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MAHLY vs NSVGF: Fundamental Ratings
MAHLY
NSVGF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
37100
PRICE GROWTH RATING
1..100
5170
P/E GROWTH RATING
1..100
23100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MAHLY's Valuation (92) in the null industry is in the same range as NSVGF (93). This means that MAHLY’s stock grew similarly to NSVGF’s over the last 12 months.

MAHLY's Profit vs Risk Rating (92) in the null industry is in the same range as NSVGF (100). This means that MAHLY’s stock grew similarly to NSVGF’s over the last 12 months.

MAHLY's SMR Rating (37) in the null industry is somewhat better than the same rating for NSVGF (100). This means that MAHLY’s stock grew somewhat faster than NSVGF’s over the last 12 months.

MAHLY's Price Growth Rating (51) in the null industry is in the same range as NSVGF (70). This means that MAHLY’s stock grew similarly to NSVGF’s over the last 12 months.

MAHLY's P/E Growth Rating (23) in the null industry is significantly better than the same rating for NSVGF (100). This means that MAHLY’s stock grew significantly faster than NSVGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYNSVGF
RSI
ODDS (%)
Bearish Trend 3 days ago
57%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
45%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
35%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
29%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
36%
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
36%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPXS14.070.11
+0.79%
Optex Systems Holdings
VC97.300.34
+0.35%
Visteon Corp
RPRX39.22-0.03
-0.08%
Royalty Pharma plc
AMBQ30.00-0.83
-2.69%
Ambiq Micro Inc
CCTG0.13-0.03
-18.56%
CCSC Technology International Holdings Limited

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and PDRX have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
N/A
COSM - MAHLY
2%
Poorly correlated
-2.22%
SHTDF - MAHLY
1%
Poorly correlated
N/A
More

NSVGF and

Correlation & Price change

A.I.dvisor tells us that NSVGF and SHPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSVGF and SHPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSVGF
1D Price
Change %
NSVGF100%
N/A
SHPMY - NSVGF
14%
Poorly correlated
N/A
PDRX - NSVGF
8%
Poorly correlated
N/A
SHTDF - NSVGF
4%
Poorly correlated
N/A
AMFPF - NSVGF
1%
Poorly correlated
N/A
MAHLY - NSVGF
1%
Poorly correlated
N/A
More